DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Biogen Idec (NASDAQ: BIIB)

318.78 1.78 (0.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $318.78 0.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $319.57
Previous Close $317.00
Daily Range $312.70 - $322.35
52-Week Range $290.85 - $480.18
Market Cap $75.0B
P/E Ratio 21.40
Dividend (Yield) $0.00 (0.0%)
Volume 2,241,797
Average Daily Volume 2,587,773
Current FY EPS $16.01

Sector

Healthcare

Industry

Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

The Blockbuster Potential of Biogen Inc's Pipeline

Blue chip biotech stock Biogen has a strong pipeline full of drugs that could offer multi billion dollar opportunity. Lets take a closer look at the potential.

Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'

Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More

Acorda 2Q Earnings & Revenues Top, Ampyra in Focus - Analyst Blog

Earnings Season: The Good, The Bad, And The Ugly. And Why I Remain A Bull

Today's Market: Biotech Earnings Remain Strong, Apple's Next Revamped Product

The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases

Attention New Biotech Investors: Biogen Inc's Recent Weakness Is Your Opportunity

Biogen's stock has fallen hard recently based on slower than expected earnings growth of Tecfidera. Still, the company boasts a number of billion dollar drugs and a strong pipeline that make it an ideal choice for new biotech investors.

3 Stocks Pushing The Drugs Industry Lower

Gilead Q2 Earnings: KAPOW! BAM! BOOM! (Yes, That Good)

See More BIIB News...

BIIB's Top Competitors

BIIB $318.78 (0.56%)
Current stock: BIIB
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
$0.00 (0.00%)
Current stock: